Barry S. Starkman

Merck & Co., Inc., Rahway, NJ, USA (United States)

Papers

Total Citations

162

H-Index

About

Barry S. Starkman is a leading authority in occupational and environmental health, with a specialized focus on the pharmaceutical industry. His primary research areas include the development of performance-based exposure control limits for active pharmaceutical ingredients (APIs) and the advancement of industrial hygiene practices. Starkman’s most significant contribution is his seminal 1996 paper, "Performance-Based Exposure Control Limits for Pharmaceutical Active Ingredients," which has garnered 151 citations. This work revolutionized how pharmaceutical companies establish employee exposure limits, moving beyond traditional risk assessment methods to more selective, performance-driven criteria. By addressing the industry’s shift toward highly potent and selective APIs, Starkman provided a framework that balances worker safety with operational efficiency. His research has had a profound impact on regulatory standards and corporate safety protocols, influencing how companies manage occupational exposure to potent compounds. With a career dedicated to bridging toxicology and industrial hygiene, Starkman’s work remains a cornerstone for professionals seeking to protect workers in high-stakes pharmaceutical environments. His insights continue to guide both academic research and practical applications in exposure science.